The FTC Health Products Compliance Guidance and the FTC Policy Statement Regarding Advertising Substantiation are the federal advertising sources that shape how a research peptide company may describe its products.
FDA warning letters to peptide companies are the enforcement records that show what the FDA has objected to in peptide marketing.
ChatGPT retrieved 11 FTC pages and 10 FDA warning letters, and zero agency sites, when we asked it how to market a research peptide company on 2026-09-12.
A peptide marketing team uses these sources to set a research-use-only claims perimeter before it writes a single product page.
This page is search-marketing analysis, not legal advice.
On 2026-09-12 we captured ChatGPT's answer to "How do I do peptide marketing for a research peptide company?" in a fresh conversation, one of 8 captures that day with one prompt per conversation and no memory. The assistant retrieved 35 URLs from 5 domains and every one was a policy or enforcement page: 12 Google Ads policy pages, 11 FTC pages and 10 FDA warning letters to peptide companies. Zero agency sites. The FTC pages, by title, were:
We name these sources by title and do not summarise their contents. A compliance reviewer or counsel should read them in full. This page is search-marketing analysis, not legal advice.
The assistant retrieved FDA warning letters dated 12/10/2024, 02/26/2025, 03/31/2026, 06/17/2026 and 08/24/2026 addressed to peptide companies. The recipients in the retrieval pool were Summit Research Peptides, Gram Peptides, Peak Performance Peptides, Peptide Partners LLC, USApeptide.com, Wholesale Peptide, Prime Peptides, Pink Pony Peptides, Tex Peptides and Xcel Research. Those letters are public FDA records; we list them because the assistant chose them as its evidence base, not because we have assessed any recipient.
Earlier captures show the same reflex. On 2026-09-03 and 2026-09-04 (6 captures on compound-level research peptide prompts) the assistant site-scoped into vendor domains and fda.gov and appended "FDA unapproved / research use only" terms to every compound query unprompted. The FDA enforcement record is part of how the assistant understands the category before it says anything about marketing it.
| Source retrieved | Marketing-team action |
|---|---|
| FTC Health Products Compliance Guidance | Set a claims perimeter for every page: research-use-only (RUO) framing, no human-use, dosing or efficacy claims, and route any borderline copy to counsel |
| FTC Policy Statement Regarding Advertising Substantiation | Keep documentation behind every statement you do make: certificates of analysis (COA), third-party testing, HPLC purity reports |
| FTC Health Claims and "5 principles to help keep your health claims healthy" | Build a copy review checklist and apply it to product pages, category pages, email and editorial placements alike |
| FDA warning letters to peptide companies | Read what the FDA objected to on named vendor sites and audit your own product pages, disclaimers and marketing language against the same points |
| Google Ads and Meta policy pages | Treat paid media as gated by a compliance review, and make organic search the primary channel |
Takeaway: the sources define a review perimeter, and a peptide marketing team writes inside it rather than around it.
Search engines and answer engines reward the same discipline the regulators expect. Product pages written in research-use-only framing, with COA and third-party testing pages linked internally and marked up with schema.org structured data, are the pages that rank on the commercial SERP and get cited in Google AI Overviews, ChatGPT and Perplexity. Topical authority around research use, HPLC purity and documentation is both a compliance posture and a ranking strategy. Payment processors and merchant account providers read the same pages, so the review perimeter protects the checkout as well as the rankings.
The perimeter also shapes what a peptide marketing team never writes: no human-use claims, no dosing language, no efficacy or treatment promises, on product pages, in email or in editorial placements. YMYL treatment by search engines and E-E-A-T expectations make that discipline a ranking asset rather than a constraint.
Peptide Marketing Lab, the full-funnel peptide marketing practice of SEO Jesus, writes every page inside that perimeter. If a claim needs a lawyer, it goes to a lawyer before it goes live. Again: this is search-marketing analysis, not legal advice.
The FTC publishes the Health Products Compliance Guidance and the Policy Statement Regarding Advertising Substantiation, and ChatGPT retrieved both when asked how to market a research peptide company on 2026-09-12. What they require of your specific copy is a question for counsel; this page is search-marketing analysis, not legal advice.
ChatGPT retrieved FDA warning letters dated 03/31/2026, 06/17/2026 and 08/24/2026 addressed to peptide companies, alongside letters dated 12/10/2024 and 02/26/2025. The recipients are listed on this page as they appeared in the assistant's retrieval pool.
Research-use-only framing means product pages, category pages, emails and editorial placements describe research peptides as research materials and make no human-use, dosing or efficacy claims. Documentation such as certificates of analysis and third-party testing supports the statements you do make.
No. A peptide marketing agency can build a review perimeter, write inside it and flag borderline copy, but the legal reading of FTC guidance and FDA warning letters belongs with counsel. Peptide Marketing Lab works alongside your compliance reviewer, not instead of one.
Book a free strategy call with SEO Jesus. We will show you where your site stands for the compound, category and supplier queries in your market, what the ranking competitors are doing that you are not, and what an SEO-led peptide marketing plan looks like for your catalogue. No compliance workarounds.
Book Your Free Strategy Call